BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10457531)

  • 1. Ionotropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain.
    Healy DJ; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Sep; 21(3):341-51. PubMed ID: 10457531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release.
    Marcos B; Gil-Bea FJ; Hirst WD; García-Alloza M; Ramírez MJ
    Eur J Neurosci; 2006 Sep; 24(5):1299-306. PubMed ID: 16987217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionotropic glutamate receptor modulation preferentially affects NMDA receptor expression in rat hippocampus.
    Healy DJ; Meador-Woodruff JH
    Synapse; 2000 Dec; 38(3):294-304. PubMed ID: 11020232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.
    Schechter LE; Lin Q; Smith DL; Zhang G; Shan Q; Platt B; Brandt MR; Dawson LA; Cole D; Bernotas R; Robichaud A; Rosenzweig-Lipson S; Beyer CE
    Neuropsychopharmacology; 2008 May; 33(6):1323-35. PubMed ID: 17625499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors.
    Bonsi P; Cuomo D; Ding J; Sciamanna G; Ulrich S; Tscherter A; Bernardi G; Surmeier DJ; Pisani A
    Neuropsychopharmacology; 2007 Aug; 32(8):1840-54. PubMed ID: 17203014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo modulation of nitric oxide concentration dynamics upon glutamatergic neuronal activation in the hippocampus.
    Lourenço CF; Santos R; Barbosa RM; Gerhardt G; Cadenas E; Laranjinha J
    Hippocampus; 2011 Jun; 21(6):622-30. PubMed ID: 20169537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of repeated MK-801 administration on the glutamate receptor gene expression in the rat hippocampus.
    Lasoń W; Turchan J; Przewłocka B; Labuz D; Przewłocki R
    Pol J Pharmacol; 1997 Aug; 49(4):249-53. PubMed ID: 9437768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling following chronic NMDA receptor blockade-induced learning deficits in rats.
    O'Donnell J; Stemmelin J; Nitta A; Brouillette J; Quirion R
    Synapse; 2003 Dec; 50(3):171-80. PubMed ID: 14515334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An mRNA expression analysis of stimulation and blockade of 5-HT7 receptors during memory consolidation.
    Pérez-García G; Gonzalez-Espinosa C; Meneses A
    Behav Brain Res; 2006 Apr; 169(1):83-92. PubMed ID: 16480781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons.
    Guerra MJ; Liste I; Labandeira-Garcia JL
    Synapse; 1998 Jan; 28(1):71-82. PubMed ID: 9414020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
    Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior.
    Ballaz SJ; Akil H; Watson SJ
    Neuroscience; 2007 Jun; 147(2):428-38. PubMed ID: 17543469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cholecystokinin mRNA content in rat striatum: a glutamatergic hypothesis.
    Ding XZ; Mocchetti I
    J Pharmacol Exp Ther; 1992 Oct; 263(1):368-73. PubMed ID: 1403798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenfluramine-induced increase in preproenkephalin mRNA levels in the striatum: interaction between the serotonergic, glutamatergic, and dopaminergic systems.
    Liste I; Muñoz A; Guerra MJ; Labandeira-Garcia JL
    Synapse; 2000 Mar; 35(3):182-91. PubMed ID: 10657025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-course of 5-HT(6) receptor mRNA expression during memory consolidation and amnesia.
    Huerta-Rivas A; Pérez-García G; González-Espinosa C; Meneses A
    Neurobiol Learn Mem; 2010 Jan; 93(1):99-110. PubMed ID: 19733250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission.
    Tassone A; Madeo G; Schirinzi T; Vita D; Puglisi F; Ponterio G; Borsini F; Pisani A; Bonsi P
    Neuropharmacology; 2011 Sep; 61(4):632-7. PubMed ID: 21619890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains.
    Noga JT; Hyde TM; Herman MM; Spurney CF; Bigelow LB; Weinberger DR; Kleinman JE
    Synapse; 1997 Nov; 27(3):168-76. PubMed ID: 9329152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative.
    Meneses A
    Rev Neurosci; 2014; 25(3):325-56. PubMed ID: 24698823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate and regulation of proliferation in the developing mammalian telencephalon.
    Luk KC; Sadikot AF
    Dev Neurosci; 2004; 26(2-4):218-28. PubMed ID: 15711062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.